{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:51:18Z","timestamp":1776455478375,"version":"3.51.2"},"reference-count":100,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:00:00Z","timestamp":1614384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Phosphorus is an essential nutrient that is critically important in the control of cell and tissue function and body homeostasis. Phosphorus excess may result in severe adverse medical consequences. The most apparent is an impact on cardiovascular (CV) disease, mainly through the ability of phosphate to change the phenotype of vascular smooth muscle cells and its contribution to pathologic vascular, valvular and other soft tissue calcification. Chronic kidney disease (CKD) is the most prevalent chronic disease manifesting with the persistent derangement of phosphate homeostasis. Diabetes and resulting diabetic kidney disease (DKD) remain the leading causes of CKD and end-stage kidney disease (ESRD) worldwide. Mineral and bone disorders of CKD (CKD-MBD), profound derangement of mineral metabolism, develop in the course of the disease and adversely impact on bone health and the CV system. In this review we aimed to discuss the data concerning CKD-MBD in patients with diabetes and to analyze the possible link between hyperphosphatemia, certain biomarkers of CKD-MBD and high dietary phosphate intake on prognosis in patients with diabetes and DKD. We also attempted to clarify if hyperphosphatemia and high phosphorus intake may impact the onset and progression of DKD. Careful analysis of the available literature brings us to the conclusion that, as for today, no clear recommendations based on the firm clinical data can be provided in terms of phosphorus intake aiming to prevent the incidence or progression of diabetic kidney disease.<\/jats:p>","DOI":"10.3390\/nu13030789","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T20:55:44Z","timestamp":1614459344000},"page":"789","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dietary Phosphorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease"],"prefix":"10.3390","volume":"13","author":[{"given":"Agata","family":"Winiarska","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0576-0079","authenticated-orcid":false,"given":"Iwona","family":"Filipska","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Knysak","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Stomp\u00f3r","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hypertension and Internal Medicine, University of Warmia and Mazury in Olsztyn, 10561 Olsztyn, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3945\/an.115.008516","article-title":"Phosphorus","volume":"6","author":"Calvo","year":"2015","journal-title":"Adv. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","article-title":"Regulation of serum phosphate","volume":"592","author":"Lederer","year":"2014","journal-title":"J. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Serna, J., and Bergwitz, C. (2020). Importance of Dietary Phosphorus for Bone Metabolism and Healthy Aging. Nutr., 12.","DOI":"10.3390\/nu12103001"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MNH.0b013e3283621310","article-title":"The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease","volume":"22","author":"Marks","year":"2013","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MNH.0000000000000053","article-title":"Renal phosphate transporters","volume":"23","author":"Lederer","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-013-1418-6","article-title":"The SLC34 family of sodium-dependent phosphate transporters","volume":"466","author":"Wagner","year":"2013","journal-title":"Pfl\u00fcgers Archiv Eur. J. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Massy","year":"2016","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MNH.0b013e32835422c4","article-title":"Fibroblast growth factor 23 and the heart","volume":"21","author":"Faul","year":"2012","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease","volume":"5","author":"Gutekunst","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/MD.0000000000000106","article-title":"Combined Alkaline Phosphatase and Phosphorus Levels as a Predictor of Mortality in Maintenance Hemodialysis Patients","volume":"93","author":"Chang","year":"2014","journal-title":"Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease","volume":"6","author":"Moe","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","article-title":"Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease","volume":"26","author":"Isakova","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2015.284","article-title":"Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3\u20135: The Modification of Diet in Renal Disease Study","volume":"89","author":"Selamet","year":"2016","journal-title":"Kidney Int."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1038\/s41598-017-10390-2","article-title":"The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction","volume":"7","author":"Schnitzbauer","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40265-018-0950-2","article-title":"Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease","volume":"78","author":"Fouque","year":"2018","journal-title":"Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1681\/ASN.2018080832","article-title":"Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial","volume":"30","author":"Block","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e10242","DOI":"10.1002\/jbm4.10242","article-title":"Mineral and Electrolyte Disorders With SGLT2i Therapy","volume":"3","author":"Cianciolo","year":"2019","journal-title":"JBMR Plus"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Hou, Y.-C., Zheng, C.-M., Yen, T.-H., and Lu, K.-C. (2020). Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217833"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacc.2019.11.036","article-title":"Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors","volume":"75","author":"Zelniker","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMc1917241","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"382","author":"Peled","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"Wheeler","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.1800160115","article-title":"Insulin suppresses the production of fibroblast growth factor 23 (FGF23)","volume":"115","author":"Feger","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdiacomp.2013.09.004","article-title":"Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3\u20135 chronic kidney disease patients","volume":"28","author":"Garland","year":"2014","journal-title":"J. Diabetes Its Complicat."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hanks, L.J., Casazza, K., Judd, S.E., Jenny, N.S., and Guti\u00e9rrez, O.M. (2015). Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults. PLOS ONE, 10.","DOI":"10.1371\/journal.pone.0122885"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02624688","article-title":"Effect of phosphate omission on the glucose-induced insulin releasein vitro in fed and fasted rats","volume":"19","author":"Castillo","year":"1982","journal-title":"Acta Diabetol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ejcn.1602375","article-title":"Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects","volume":"60","author":"Haap","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.clnu.2017.07.025","article-title":"High dietary phosphorus intake is associated with an increased risk of type 2 diabetes in the large prospective E3N cohort study","volume":"37","author":"Mancini","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc20-1913","article-title":"Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000\u20132015","volume":"44","author":"Cheng","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fcell.2019.00314","article-title":"Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale","volume":"7","author":"Provenzano","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2013.12.013","article-title":"Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)","volume":"64","author":"Haynes","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"III-27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of Endothelial Dysfunction in Atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/157016106777698469","article-title":"Role of Oxidative Stress in Development of Cardiovascular Complications in Diabetes Mellitus","volume":"4","author":"Haidara","year":"2006","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4158\/EP.12.S1.47","article-title":"Postprandial Hyperglycemia and Cardiovascular Disease","volume":"12","author":"Gerich","year":"2006","journal-title":"Endocr. Pr."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., Mallamaci, F., and Zoccali, C. (2020). Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. J. Clin. Med., 9.","DOI":"10.3390\/jcm9082359"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0272-6386(04)00820-0","article-title":"Trends and dynamics of changes in calcification score over the 1-year observation period in patients on peritoneal dialysis","volume":"44","author":"Pasowicz","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/ajkd.2003.50005","article-title":"An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis","volume":"41","author":"Pasowicz","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"ref_45","first-page":"863","article-title":"Combined effects of hyperphosphatemia and hyperglycemia on the calcification of cultured human aortic smooth muscle cells","volume":"17","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human Vascular Smooth Muscle Cells Undergo Vesicle-Mediated Calcification in Response to Changes in Extracellular Calcium and Phosphate Concentrations: A Potential Mechanism for Accelerated Vascular Calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage Phenotype and Function in Different Stages of Atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ki.2013.145","article-title":"No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease","volume":"84","author":"Mehrotra","year":"2013","journal-title":"Kidney Int."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of Phosphorus and Calcium-Phosphorus Product With Mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease","volume":"16","author":"Kestenbaum","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circ."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MNH.0b013e328343ea70","article-title":"Increased serum phosphate and adverse clinical outcomes: Unraveling mechanisms of disease","volume":"20","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.carpath.2012.02.008","article-title":"Phosphate: a stealthier killer than previously thought?","volume":"21","author":"Egido","year":"2012","journal-title":"Cardiovasc. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.2042-7158.2012.01561.x","article-title":"Role of fetuin-A in atherosclerosis associated with diabetic patients","volume":"64","author":"Singh","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s10792-017-0750-9","article-title":"Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients","volume":"38","author":"Yilmaz","year":"2017","journal-title":"Int. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e13287","DOI":"10.14814\/phy2.13287","article-title":"Fetuin-A aggravates lipotoxicity in podocytes via interleukin-1 signaling","volume":"5","author":"Orellana","year":"2017","journal-title":"Physiol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/liv.12478","article-title":"Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects","volume":"35","author":"Sato","year":"2014","journal-title":"Liver Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III","volume":"99","author":"Chang","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/ndt\/gfr367","article-title":"Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III","volume":"27","author":"Murtaugh","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ki.2012.303","article-title":"Dietary phosphorus is associated with greater left ventricular mass","volume":"83","author":"Yamamoto","year":"2013","journal-title":"Kidney Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1475-2891-12-94","article-title":"Associations among total and food additive phosphorus intake and carotid intima-media thickness\u2014A cross-sectional study in a middle-aged population in Southern Finland","volume":"12","author":"Itkonen","year":"2013","journal-title":"Nutr. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/135287","article-title":"Disturbance of Inorganic Phosphate Metabolism in Diabetes Mellitus: Its Relevance to the Pathogenesis of Diabetic Retinopathy","volume":"2014","author":"Vorum","year":"2014","journal-title":"J. Ophthalmol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/157339910793360833","article-title":"Disturbance of inorganic phosphate metabolism in diabetes mellitus: Its impact on the development of diabetic late complications","volume":"6","author":"Ditzel","year":"2010","journal-title":"Curr. Diabetes Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/DMSO.S6338","article-title":"Disturbance of inorganic phosphate metabolism in diabetes mellitus: Temporary therapeutic inter-vention trials","volume":"2","author":"Ditzel","year":"2009","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease","volume":"26","author":"Hwang","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Chang, W.X., Xu, N., Kumagai, T., Shiraishi, T., Kikuyama, T., Omizo, H., Sakai, K., Arai, S., Tamura, Y., and Ota, T. (2016). The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154469"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/nep.12724","article-title":"The association between plasma phosphorus and renal outcome - a prospective cohort of patients majorly with glomerulonephritis","volume":"22","author":"Xu","year":"2016","journal-title":"Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","article-title":"Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies","volume":"66","author":"Da","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.17219\/acem\/70094","article-title":"Phosphorus is an independent risk factor for the progression of diabetic nephropathy","volume":"27","author":"Xiang","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.diabres.2013.03.007","article-title":"The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients","volume":"100","author":"Chen","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2014.08.037","article-title":"Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study","volume":"237","author":"Brandenburg","year":"2014","journal-title":"Atheroscler."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000497125","article-title":"Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment","volume":"49","author":"Emrich","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ejhf.1749","article-title":"Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: Data from the TIME-CHF trial","volume":"22","author":"Brandenburg","year":"2020","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2215\/CJN.12821216","article-title":"Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease","volume":"12","author":"Chonchol","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1681\/ASN.2012070713","article-title":"Mineral Metabolites and CKD Progression in African Americans","volume":"24","author":"Scialla","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2215\/CJN.06190614","article-title":"Fibroblast Growth Factor 23 and Incident CKD in Type 2 Diabetes","volume":"10","author":"Isakova","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy","volume":"6","author":"Titan","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/ndt\/gfu255","article-title":"A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_83","first-page":"1608","article-title":"Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling","volume":"26","author":"Courbebaisse","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3945\/ajcn.116.151654","article-title":"High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: A community-based prospective cohort study","volume":"106","author":"Yoon","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/ki.2013.258","article-title":"Serum phosphorus in people with chronic kidney disease: You are what you eat","volume":"84","author":"Tonelli","year":"2013","journal-title":"Kidney Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD) Guideline Update: What\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"(2017). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD). Kidney Int. Suppl., 7, 1\u201359.","DOI":"10.1016\/j.kisu.2017.04.001"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of Phosphate Binders in Moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus Binders and Survival on Hemodialysis","volume":"20","author":"Isakova","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Locatelli","year":"2013","journal-title":"Kidney Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis","volume":"382","author":"VanderMeer","year":"2013","journal-title":"Lancet"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials","volume":"11","author":"Patel","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40620-019-00689-w","article-title":"Phosphate binders in chronic kidney disease: An updated narrative review of recent data","volume":"33","author":"Floege","year":"2019","journal-title":"J. Nephrol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s12011-020-02218-4","article-title":"Iron Overload Resulting from the Chronic Oral Administration of Ferric Citrate Impairs Intestinal Immune and Barrier in Mice","volume":"199","author":"Luo","year":"2021","journal-title":"Biol. Trace Element Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s40265-017-0758-5","article-title":"A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?","volume":"77","author":"Peter","year":"2017","journal-title":"Drugs"},{"key":"ref_96","first-page":"CD006023","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"8","author":"Ruospo","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"On behalf of the INDEPENDENT study investigators Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study","volume":"7","author":"Bellasi","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1542-4758.2009.00394.x","article-title":"Treating mineral metabolism disorders in patients undergoing long hemodialysis: A search for an optimal strategy","volume":"13","author":"Jean","year":"2009","journal-title":"Hemodial. Int."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease","volume":"98","author":"Caramori","year":"2020","journal-title":"Kidney Int."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2021). Standards of medical care in diabetes-2021. Diabetes Care, 44, S1\u2013S232.","DOI":"10.2337\/dc21-Srev"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/789\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:30:04Z","timestamp":1760160604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/3\/789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,27]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["nu13030789"],"URL":"https:\/\/doi.org\/10.3390\/nu13030789","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,27]]}}}